The Lung Cancer Registry has launched a landmark new survey on the impact of lung cancer treatments on women’s sexual health. The aim is to explore the magnitude of the problem and give researchers and clinicians new insights to improve the quality of life for women lung cancer survivors. Learn more about lung cancer’s impact on sexual health here.
Sexual Health Assessment in Women with Lung Cancer (SHAWL) is the first comprehensive look at the impact of a lung cancer diagnosis on a women’s sexual quality of life. The SHAWL survey asks intimate and blunt questions about women’s sexual activity, questions that don’t get asked enough according to the lead investigator, Dr. Narjust Florez (Duma).
The SHAWL survey enrollment closed on March 31, 2021 and initial data was shared by Dr. Florez (Duma) at The 2022 IASLC World Conference on Lung Cancer.